Pfizer Inc
Change company Symbol lookup
Select an option...
PFE Pfizer Inc
JGGC Jaguar Global Growth Corporation I
WHG Westwood Holdings Group Inc
BNOX Bionomics Ltd
PSO Pearson PLC
ERNA Eterna Therapeutics Inc
INDP Indaptus Therapeutics Inc
TSLX Sixth Street Specialty Lending Inc
WAVD Wavedancer Inc
SGBX Safe & Green Holdings Corp
Go

Health Care : Pharmaceuticals | Large Cap Value
Company profile

Pfizer Inc. is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products around the world. The Company operates through two segments: Biopharma and PC1. Biopharma is engaged in the science-based biopharmaceutical business. PC1 is its global contract development and manufacturing organization and supplier of specialty active pharmaceutical ingredients. The Company’s primary care products include Eliquis, Nurtec ODT/Vydura and the Premarin family; the Prevnar family, Nimenrix, FSME/IMMUN-TicoVac and Trumenba; Comirnaty, and Paxlovid. Its specialty care products include Xeljanz, Enbrel (outside the United States and Canada), Inflectra, Eucrisa/Staquis and Cibinqo; the Vyndaqel family, Oxbryta, BeneFIX and Genotropin, and Sulperazon, Medrol, Zavicefta, Zithromax, Vfend and Panzyga. Its oncology products include Ibrance, Xtandi, Inlyta, Retacrit, Lorbrena and Braftovi.

Postmarket

Last Trade
Delayed
$32.14
0.05 (0.16%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$32.09
Day's Change
-0.01 (-0.03%)
Bid
--
Ask
--
B/A Size
--
Day's High
32.32
Day's Low
31.77
Volume
(Average)
Volume:
28,192,328

10-day average volume:
29,545,493
28,192,328

Display:

Providers:

UpdateCancel
All providers
Today's News, September 28, 2023
Pfizer Inc. Stock Falls Thursday, Underperforms Market

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Pfizer Inc. (PFE) sank 0.03% to $32.09 Thursday, on what proved to be an all-around favorable trading session for the stock...(MarketWatch)

Yesterday's News, September 27, 2023
Pfizer Inc. Stock Outperforms Competitors Despite Losses On The Day

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Pfizer Inc. (PFE) slipped 0.93% to $32.10 Wednesday, on what proved to be an all-around mixed trading session for the stock...(MarketWatch)

Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock

Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.(Zacks)

Ginkgo Bioworks Announces Multi-Target RNA Discovery Collaboration with Pfizer

Ginkgo Bioworks (NYSE: DNA) today announced a collaboration with Pfizer (NYSE: PFE) focused on the discovery of RNA-based drug candidates. In the collaboration, Pfizer will leverageGinkgo's proprietary RNA technology to advance the discovery and...(PR Newswire)

September 26, 2023
Pfizer Inc. Stock Falls Tuesday, Underperforms Market

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Pfizer Inc. (PFE) slid 1.76% to $32.40 Tuesday, on what proved to be an all-around grim trading session for the stock market...(MarketWatch)

Global Medical Device Packaging Market Size Expected to Reach $50 Billion By 2028

FinancialNewsMedia.com News Commentary - The Global Medical Device Packaging market is anticipated to continue its growth rate in several coming years. Medical device packaging applications employ various materials and methods. The packaging...(PR Newswire)

Pfizer restarts production at tornado-damaged facility, but some supply is still affected

By Claudia Assis 'Some medicines may not be back in full supply until next year,' Pfizer says Pfizer Inc. said late Monday that it has restarted production at a North Carolina facility badly damaged by a tornado in July, but...(MarketWatch)

FDA Accepts Sanofi's (SNY) sBLA for Dupixent in Pediatric EoE

If this filing is approved, Sanofi (SNY)/Regeneron's (REGN) Dupixent will be the first FDA-approved treatment for eosinophilic esophagitis in children aged 1 to 11. A final decision is expected in January.(Zacks)

September 25, 2023
Pfizer (PFE) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, Pfizer (PFE) closed at $32.98, marking a +0.89% move from the previous day.(Zacks)

Pfizer Inc. Stock Rises Monday, Outperforms Market

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Pfizer Inc. (PFE) inched 0.89% higher to $32.98 Monday, on what proved to be an all-around positive trading session for the...(MarketWatch)

CDC Recommends Pfizer's (PFE) RSV Jab to Protect Newborns

Pfizer's (PFE) Abrysvo has been recommended by the CDC for preventing RSV in infants by immunizing pregnant women, during weeks 32-36 of pregnancy.(Zacks)

The Zacks Analyst Blog Highlights Pfizer, Merck and AstraZeneca

Pfizer, Merck and AstraZeneca are part of the Zacks top Analyst Blog.(Zacks)

The Zacks Analyst Blog Highlights Pfizer, Merck and AstraZeneca

Pfizer, Merck and AstraZeneca are part of the Zacks top Analyst Blog.(Zacks)

September 24, 2023
Have you gotten your shot? 5 things to know about the new COVID-19 vaccine.

By Charles Passy The shot, which guards against the current variants, is now available It may be time to get your COVID-19 vaccine again. There's a new shot that's now available to guard against the virus. The Centers...(MarketWatch)

September 22, 2023
Pfizer maternal RSV vaccine recommended by CDC

By Eleanor Laise New shot aims to protect babies from a leading cause of hospitalization The Centers for Disease Control and Prevention on Friday recommended pregnant people get Pfizer Inc.'s (PFE) maternal vaccine to protect...(MarketWatch)

Pfizer Inc. Stock Outperforms Competitors Despite Losses On The Day

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Pfizer Inc. (PFE) slipped 0.49% to $32.69 Friday, on what proved to be an all-around rough trading session for the stock market...(MarketWatch)

Pfizer Broadens Portfolio of Respiratory Vaccines Recommended by CDC Advisory Committee with ABRYSVO(TM) for RSV

Pfizer Inc. (NYSE: PFE) shared today it has broadened its portfolio of respiratory vaccines recommended by the U.S. Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) following a favorable vote for...(BusinessWire)

Pharma Stock Roundup: EU Nod to PFE's Litfulo, FDA Priority Tag to MRK Applications

The European Commission approves Pfizer's (PFE) Litfulo for severe alopecia areata. FDA gives priority tag to Merck's (MRK) supplemental applications for Welireg and Keytruda.(Zacks)

September 21, 2023
Pfizer Inc. Stock Underperforms Thursday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Pfizer Inc. (PFE) slid 2.29% to $32.85 Thursday, on what proved to be an all-around dismal trading session for the stock market...(MarketWatch)

September 20, 2023
Pfizer Inc. Stock Falls Wednesday, Underperforms Market

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Pfizer Inc. (PFE) slid 1.09% to $33.62 Wednesday, on what proved to be an all-around grim trading session for the stock market...(MarketWatch)

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.